Oberweis Asset Management’s Core Laboratories CLB Stock Holding History

Oberweis Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,770	Closed	-$343K	–	144
2016 Q2	$343K	Sell	2,770 -400	-13%	-$48.3K	0.1%	133
2016 Q1	$356K	Sell	3,170 -1,000	-24%	-$104K	0.1%	143
2015 Q4	$453K	Sell	4,170 -1,030	-20%	-$118K	0.13%	133
2015 Q3	$519K	Buy	+5,200	New	+$566K	0.15%	85

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Oberweis Asset Management's CLB Position: Q3 2016 in Review

Oberweis Asset Management sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 2,770 shares — an estimated $343K sold.

Oberweis Asset Management first reported a position in CLB in Q3 2015 and held it in 4 quarters. The position peaked at $519K in Q3 2015. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Oberweis Asset Management reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Oberweis Asset Management sold 2,770 Core Laboratories shares in Q3 2016, an estimated $343K.
Oberweis Asset Management first reported a position in Core Laboratories in Q3 2015 and held it in 4 quarters.
Oberweis Asset Management's Core Laboratories position peaked at $519K in Q3 2015.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Oberweis Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.